Abstract
No public abstract is available from the verified source records.
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Widening horizon of pharmacoeconomics and outcomes research in the Asia-Pacific region
10.1016/j.vhri.2012.03.017 · 2012
10.1016/j.vhri.2013.01.008
10.1016/j.vhri.2013.01.008
Burden of disease and economic impact of dengue and severe dengue in Colombia 2011
10.1016/j.vhri.2012.09.014 · 2012
Cost-effectiveness analysis of hepatitis immunization in Vietnam: application of cost-effectiveness affordability curves in health care decision making
10.1016/j.vhri.2012.03.007 · 2012
Cost utility of sirolimus versus tacrolimus for the primary prevention of graft rejection in renal transplant recipients in Mexico
10.1016/j.vhri.2012.09.013 · 2012
Costo efectividad del tratamiento de tumours neuroendocrinos pancreaticos avanzados no operable con sunitinib en Mexico
10.1016/j.vhri.2012.10.005 · 2012
Performing country-led economic evaluations to inform immunization policy: ProVac experiences in Latin America and the Caribbean
10.1016/j.vhri.2012.10.003 · 2012
Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force Report
10.1111/j.1524-4733.2008.00489.x · 2009
Key principles for the improved conduct of health technology assessments for resource allocation decisions
10.1017/s0266462308080343 · 2008
Health technology assessment for resource allocation decisions: are key principles relevant for Latin America?
10.1017/s0266462310001042 · 2010
No additional external references are available.